课题基金 / 基金详情

Enhancing brain development by early iron supplementation of African infants: An enabling pilot study

Enhancing brain development by early iron supplementation of African infants: An enabling pilot study
通过非洲婴儿早期补铁促进大脑发育:一项有利的试点研究
批准号:
MR/T003960/1
负责人:
Carla Cerami
金额:
$25.61万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --

项目摘要

项目成果

Carla Cerami的其他基金

相似基金

相关文献

中文摘要
翻译
铁对大脑发育至关重要,婴儿期早期缺铁会造成无法弥补的损害。最新的全球疾病负担分析数据估计,缺铁比所有其他微量营养素缺乏症的总和还要常见。这一负担主要集中在撒哈拉以南非洲和南亚。母乳中含有很少的铁,所以婴儿在胎儿后期会利用肝脏中储存的铁。然而,缺铁母亲的婴儿出生时铁禀性有限,可能会迅速发展为缺铁。我们最近的研究表明,在5个月大的时候,几乎95%的冈比亚农村婴儿的循环铁水平低于美国参考范围的下限。这表明这些婴儿严重缺铁。美国儿科学会(AAP)建议纯母乳喂养的婴儿从4个月大开始补充铁。美国儿科学会还建议早产婴儿在两周内开始补充维生素d。然而,在低收入环境中进行的先前和正在进行的补铁试验开始的时间要晚得多(例如,在孟加拉国进行的一项正在进行的大型试验中,补铁时间为800万至900万美元)。我们的数据表明,要防止早期缺铁损害大脑发育,这已经太晚了。因此,我们建议从6周龄开始进行早期补铁的大型随机对照试验。为了准备这样的试验,我们需要对以下问题进行初步研究:我们能否通过每天给铁滴剂有效地提高婴儿早期的循环铁水平?我们能否在不影响纯母乳喂养持续时间的情况下实现这一目标?铁是否会改变婴儿肠道菌群的平衡,从而导致腹泻?铁补充剂是否会影响锌和铜的吸收,因此需要三重补充?这些问题将在一项小型研究中进行测试,该研究将为预期的全面试验的设计提供信息。
英文摘要
Iron is crucial for brain development and early deficiencies during infancy can cause irreparable damage. Figures from the latest Global Burden of Disease analysis estimate that iron deficiency is more common than all other micronutrient deficiencies combined. This burden is concentrated in sub-Saharan Africa and South Asia. Breast milk contains very little iron, so babies draw upon iron stores laid down in their liver during late foetal life. However, the babies of iron deficient mothers are born with a limited endowment of iron and can rapidly develop iron deficiency. We have recently shown that, by 5 months of age, almost 95% of rural Gambian infants have circulating iron levels below the lower limit of the US reference range. This indicates that these babies are profoundly iron deficienct. The American Academy of Pediatrics (AAP) recommends iron supplementation in exclusively breastfed infants beginning at 4 months of age. AAP also recommends that babies born prematurely start supplementation at 2 weeks. Yet prior and on-going trials of iron supplementation in low-income settings have commenced supplementation much later (eg 8-9m in a large on-going trial in Bangladesh). Our data suggest that this will be too late to prevent early iron deficiency from impairing brain development. We therefore propose a large randomised controlled trial of early iron supplementation starting at 6wks of age. In preparation for such a trial we need to conduct preliminary studies addressing the following questions: Can we effectively enhance circulating iron levels in early infancy by giving daily iron drops? Can we achieve this without undermining duration of exclusive breast feeding? Might the iron alter the balance of the babies' gut microbial flora and thereby cause diarrhoea? Might iron supplementation impair the absorption of zinc and copper and hence require a triple supplement?These questions will be tested in a small enabling study that will inform the design of the intended full trial.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Iron supplementation of breastfed Gambian infants from 6 weeks to 6 months of age: protocol for a randomised controlled trial.
对母乳喂养的冈比亚婴儿的补充6周至6个月大:随机对照试验的方案。
DOI: 10.12688/wellcomeopenres.17507.1
发表时间: 2022
期刊: Wellcome open research
影响因子: --
作者: []
通讯作者:
Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children: protocol for randomised controlled trial {1}
血红素铁与亚铁盐治疗冈比亚儿童缺铁性贫血:随机对照试验方案{1}
DOI: 10.21203/rs.3.rs-3688022/v1
发表时间: 2024
期刊:
影响因子: --
作者: [Bah M]
通讯作者: Bah M
Early iron supplementation of exclusively breastfed African infants: a proof-of-principle, placebo-controlled, randomised, double-blinded efficacy trial
纯母乳喂养的非洲婴儿早期补铁:一项原理验证、安慰剂对照、随机、双盲疗效试验
DOI: 10.1101/2023.01.12.22284059
发表时间: 2023
期刊:
影响因子: --
作者: [Bah M]
通讯作者: Bah M
Infection, inflammation and hepcidin-mediated iron deficiency anaemia in African children
国内基金
海外基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
  • 批准号:
    82371144
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    汪雪玲
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
  • 批准号:
    82371465
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李龙宣
  • 依托单位:
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
  • 批准号:
    81801389
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    田茗源
  • 依托单位: